Status:

TERMINATED

Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Chimerism

Blood Transfusion

Eligibility:

All Genders

8+ years

Brief Summary

Blood transfusions are frequently necessary in situations in which there is a large amount of blood loss. In some individuals who receive a blood transfusion, white blood cells from the donor's blood ...

Detailed Description

Approximately 10% to 15% of injured patients who receive blood transfusions experience a condition known as transfusion-associated microchimerism. This occurs when white blood cells, or leukocytes, fr...

Eligibility Criteria

Inclusion

  • Hospitalized for traumatic injury, thermal injury, or an elective orthopedic surgical procedure from 2000 to 2003 at the University of California at Davis Medical Center
  • Received at least 1 unit of transfused red blood cells

Exclusion

  • Currently incarcerated
  • Inadequate decision-making capacity of the participant and no available surrogate decision-maker
  • Prior bone marrow or solid organ transplantation
  • Prior blood transfusion other than at the time of hospitalization
  • Any history of an autoimmune disorder prior to hospitalization

Key Trial Info

Start Date :

August 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT00441779

Start Date

August 1 2008

End Date

October 1 2011

Last Update

July 12 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, Davis, Medical Center

Sacramento, California, United States, 95817